Effectiveness and safety of enzalutamide and apalutamide in the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC): a multicenter retrospective studyShuhei Hara, Takahiro Kimura, Wataru Fukuokaya et al.|International Journal of Clinical Oncology|2024Cited by 9